Dr Quick has over 20 years’ specialist interest in GCA and PMR. She leads her Trust's ultrasound-driven GCA fast-track pathway and teaches vascular ultrasound for GCA diagnosis across the UK and internationally. In 2019 she won the BSR Paul Bacon Award for Vasculitis for work demonstrating that her pathway reduced GCA-related sight loss, improved the security of GCA diagnosis, and reduced temporal artery biopsy rates. She is a member of BSR GCA Guideline Working Group, the Eastern England Rare Autoimmune Diseases (ENRAD) GCA Panel,  the BSR National Audit GCA Steering Group, and the International GCA-PMR Study Group. Her research portfolio includes leadership of TOC STOP, the largest UK service evaluation of GCA patients following tocilizumab cessation, involving 40 NHS Trusts. She is a Trustee of the patient charity PMRGCAuk, with a keen interest in education, dissemination, and patient engagement.